Navamedic ASA (OSL:NAVA)
23.50
-0.50 (-2.08%)
Aug 15, 2025, 4:25 PM CET
Navamedic ASA Revenue
Navamedic ASA had revenue of 137.28M NOK in the quarter ending June 30, 2025, a decrease of -12.17%. This brings the company's revenue in the last twelve months to 523.56M, down -3.67% year-over-year. In the year 2024, Navamedic ASA had annual revenue of 531.44M with 3.80% growth.
Revenue (ttm)
523.56M
Revenue Growth
-3.67%
P/S Ratio
0.79
Revenue / Employee
12.47M
Employees
42
Market Cap
415.08M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 531.44M | 19.44M | 3.80% |
Dec 31, 2023 | 512.00M | 129.86M | 33.98% |
Dec 31, 2022 | 382.14M | 103.70M | 37.24% |
Dec 31, 2021 | 278.44M | 68.56M | 32.67% |
Dec 31, 2020 | 209.88M | 21.12M | 11.19% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 603.92M |
Nordhealth AS | 545.88M |
Photocure ASA | 522.86M |
ArcticZymes Technologies ASA | 102.97M |
Vistin Pharma ASA | 440.66M |
Omda AS | 442.14M |
Gentian Diagnostics ASA | 163.38M |
Lytix Biopharma AS | 608.00K |